Cipla shares in focus after cell therapy product JV with Kemwell Biopharma on January 9, 2024 at 3:24 am

The JV business is being created with the intention of selling innovative cell treatment products in the EU, Japan, and the USA.

Leave a comment

Your email address will not be published. Required fields are marked *